| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.2 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.21 | 0.2 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.2 |